John Thorp, MD
Maternal & Fetal Medicine · Cary, NCNPI 1750479044
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,203 of the $2,313 with a category attached, or 95.3%. Janssen Research & Development, LLC accounts for 86.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $2,000 and has fallen 94.5% since, to $110 in 2025.
Across 4 payments — averaging $578.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$2K
- Vertex$203
- Biogen$110
Across 53 payments — averaging $7413.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$223K
- Pfizer$170K
What the payments were for
- Consulting fees$2,20395%
- Food & beverage$1105%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 1 | $2,000 |
| Vertex | 1 | $203 |
| Biogen | 2 | $110 |
How this compares
$2,313 in reported general payments places this provider in the 80th percentile of 64 maternal & fetal medicine providers in North Carolina.
See all maternal & fetal medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 20 | $134 |
Paid to pharmacies, not to this prescriber.
Other maternal & fetal medicine in Cary
- Eric DeiganCary$41
- Ebony CarterChapel Hill$117K
- Robert HeineWinston Salem$79K
- Andra JamesDurham$40K
- Kim BoggessChapel Hill$35K
- William GoodnightChapel Hill$16K
- Jerome FederspielDurham$10K
- Asha TalatiChapel Hill$9K
- Brenna HughesDurham$6K
- James EdwardsRaleigh$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.